{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:59:31Z","timestamp":1779109171126,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Perioper Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and objectives<\/jats:title>\n            <jats:p>Remimazolam tosylate is a novel anesthetic agent known for its rapid onset, non-irritating and non-polluting properties, effective sedation with minimal respiratory depression, short duration of action, and suitability for continuous infusion. Additionally, it can be efficiently antagonized by flumazenil. This study aims to explore the feasibility and safety of Remimazolam tosylate for anesthesia induction while maintaining spontaneous respiration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This prospective, randomized controlled trial involved patients aged 18\u201365\u00a0years with non-difficult airways who were scheduled for endotracheal intubation under general anesthesia. Participants, after receiving the same protocol of dexmedetomidine sedation and Lidocaine surface anesthesia, were randomly assigned to either the sevoflurane induction group or the remimazolam tosylate induction group, with 30 patients in each group. Anesthesia induction was performed while maintaining spontaneous respiration, followed by endotracheal intubation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>All enrolled patients successfully underwent intubation, and no severe respiratory depression or other complications were observed in either group (Successful anesthesia induction intubation is defined as follows: (1) successful anesthesia induction without the need for rescue measures during the induction of anesthesia, (2) no awakening during anesthesia induction, (3) spontaneous breathing is preserved throughout the entire procedure, and (4) successful completion of intubation.). There were no statistically significant differences in heart rate, blood pressure, oxygen saturation, or blood gas results between the groups. Regarding the time required for anesthesia induction, the average time to achieve the condition for topical anesthesia to the throat was 7.3\u00a0min in the remimazolam group and 17.7\u00a0min in the sevoflurane group, which was statistically significant (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). The total time to complete intubation was 11.4\u00a0min in the remimazolam group and 21.3\u00a0min in the sevoflurane group, which was statistically significant (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). During the local anesthetic throat spray procedure, 47% of patients in the sevoflurane group and 80% in the remimazolam group experienced coughing. This difference was statistically significant. During intubation, 20% of patients in the sevoflurane group and 33% in the remimazolam group continued to cough, but this difference was not statistically significant..<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Compared with sevoflurane, remimazolam can be safely and effectively used for intubation while preserving spontaneous breathing, with a shorter time to achieve conditions for topical anesthesia and intubation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13741-025-00588-8","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:49:31Z","timestamp":1759315771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of remimazolam tosylate and sevoflurane for anesthesia induction with preserved spontaneous respiration during tracheal intubation: a prospective, single-center, randomized controlled trial"],"prefix":"10.1186","volume":"14","author":[{"given":"Yu","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"2","key":"588_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/anae.14471","volume":"74","author":"I Ahmad","year":"2019","unstructured":"Ahmad I, et al. Airway management research: a systematic review. Anaesthesia. 2019;74(2):225\u201336.","journal-title":"Anaesthesia"},{"issue":"4","key":"588_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/anae.14904","volume":"75","author":"I Ahmad","year":"2020","unstructured":"Ahmad I, et al. Difficult Airway Society guidelines for awake tracheal intubation (ATI) in adults. Anaesthesia. 2020;75(4):509\u201328.","journal-title":"Anaesthesia"},{"issue":"1","key":"588_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00540-022-03119-7","volume":"37","author":"Y Aoki","year":"2023","unstructured":"Aoki Y, et al. Association between remimazolam and postoperative delirium in older adults undergoing elective cardiovascular surgery: a prospective cohort study. J Anesth. 2023;37(1):13\u201322.","journal-title":"J Anesth"},{"issue":"4","key":"588_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/anae.14947","volume":"75","author":"MF Aziz","year":"2020","unstructured":"Aziz MF, Kristensen MS. From variance to guidance for awake tracheal intubation. Anaesthesia. 2020;75(4):442\u20136.","journal-title":"Anaesthesia"},{"issue":"6","key":"588_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bja.2024.02.005","volume":"132","author":"EC Barbosa","year":"2024","unstructured":"Barbosa EC, et al. Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. Br J Anaesth. 2024;132(6):1219\u201329.","journal-title":"Br J Anaesth"},{"issue":"23","key":"588_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014240","volume":"8","author":"C Caraballo","year":"2019","unstructured":"Caraballo C, et al. Clinical implications of the New York Heart Association classification. J Am Heart Assoc. 2019;8(23): e014240.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"588_CR7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00004714-199008000-00003","volume":"10","author":"DA Chernik","year":"1990","unstructured":"Chernik DA, et al. Validity and reliability of the Observer\u2019s Assessment of Alertness\/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244\u201351.","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"588_CR8","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.23736\/S0375-9393.21.15517-8","volume":"87","author":"G Dai","year":"2021","unstructured":"Dai G, et al. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia. Minerva Anestesiol. 2021;87(10):1073\u20139.","journal-title":"Minerva Anestesiol"},{"issue":"4","key":"588_CR9","first-page":"652","volume":"132","author":"A Eisenried","year":"2020","unstructured":"Eisenried A, et al. Pharmacokinetics and pharmacodynamics of remimazolam (cns 7056) after continuous infusion in healthy male volunteers: part II. Pharmacodynamics of Electroencephalogram Effects Anesthesiology. 2020;132(4):652\u201366.","journal-title":"Pharmacodynamics of Electroencephalogram Effects Anesthesiology"},{"issue":"1","key":"588_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11096-022-01487-4","volume":"45","author":"S Gao","year":"2023","unstructured":"Gao S, et al. Clinical effects of remimazolam alone or in combination with dexmedetomidine in patients receiving bronchoscopy and influences on postoperative cognitive function: a randomized-controlled trial. Int J Clin Pharm. 2023;45(1):137\u201345.","journal-title":"Int J Clin Pharm"},{"key":"588_CR11","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.2147\/DDDT.S384155","volume":"16","author":"Q Hu","year":"2022","unstructured":"Hu Q, et al. Remimazolam: an updated review of a new sedative and anaesthetic. Drug des Devel Ther. 2022;16:3957\u201374.","journal-title":"Drug des Devel Ther"},{"issue":"2","key":"588_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1213\/ANE.0b013e31825ef8d7","volume":"115","author":"KB Johnson","year":"2012","unstructured":"Johnson KB. New horizons in sedative hypnotic drug development: fast, clean, and soft. Anesth Analg. 2012;115(2):220\u20132.","journal-title":"Anesth Analg"},{"issue":"2","key":"588_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clinthera.2023.11.004","volume":"46","author":"KL Johnson","year":"2024","unstructured":"Johnson KL, et al. Remimazolam: a retrospective study of initial safety and recovery data in diverse procedural sedation. Clin Ther. 2024;46(2):90\u20135.","journal-title":"Clin Ther"},{"issue":"2","key":"588_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00540-022-03148-2","volume":"37","author":"S Kaneko","year":"2023","unstructured":"Kaneko S, et al. Effect of remimazolam on the incidence of delirium after transcatheter aortic valve implantation under general anesthesia: a retrospective exploratory study. J Anesth. 2023;37(2):210\u20138.","journal-title":"J Anesth"},{"issue":"1","key":"588_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40981-023-00661-5","volume":"9","author":"T Katsuragawa","year":"2023","unstructured":"Katsuragawa T, et al. Effect of remimazolam versus sevoflurane on intraoperative hemodynamics in noncardiac surgery: a retrospective observational study using propensity score matching. JA Clin Rep. 2023;9(1):70.","journal-title":"JA Clin Rep"},{"key":"588_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/DDDT.S441622","volume":"18","author":"J Lee","year":"2024","unstructured":"Lee J, et al. Comparison of Remimazolam versus Sevoflurane on the postoperative quality of recovery in cervical spine surgery: a prospective randomized controlled double-blind trial. Drug des Devel Ther. 2024a;18:121\u201332.","journal-title":"Drug des Devel Ther"},{"issue":"6","key":"588_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00540-024-03386-6","volume":"38","author":"S Lee","year":"2024","unstructured":"Lee S, et al. Retrospective comparison of the effects of remimazolam and dexmedetomidine on postoperative delirium in elderly patients undergoing orthopedic surgery of the lower extremities under spinal anesthesia. J Anesth. 2024b;38(6):771\u20139.","journal-title":"J Anesth"},{"issue":"8","key":"588_CR18","first-page":"14042","volume":"8","author":"P Li","year":"2015","unstructured":"Li P, et al. Assessment of tracheal intubation in adults after induction with sevoflurane and different doses of propofol: a randomly controlled trial. Int J Clin Exp Med. 2015;8(8):14042\u20137.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"588_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jss.2016.03.011","volume":"203","author":"LW Li","year":"2016","unstructured":"Li LW, et al. Site-directed topical lidocaine spray attenuates perioperative respiratory adverse events in children undergoing elective surgery. J Surg Res. 2016;203(1):206\u201310.","journal-title":"J Surg Res"},{"issue":"38","key":"588_CR20","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018.","journal-title":"Eur Heart J"},{"issue":"1","key":"588_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12871-024-02466-0","volume":"24","author":"F Shi","year":"2024","unstructured":"Shi F, et al. Application of remimazolam-0.6% sevoflurane anesthesia for flash visual evoked potential monitoring during pituitary adenoma resection: a non-inferiority randomized controlled trial. BMC Anesthesiol. 2024;24(1):85.","journal-title":"BMC Anesthesiol"},{"key":"588_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2147\/IJGM.S345390","volume":"15","author":"F Shi","year":"2022","unstructured":"Shi F, et al. Efficacy and safety of remimazolam tosilate versus propofol for general anesthesia in cirrhotic patients undergoing endoscopic variceal ligation. Int J Gen Med. 2022a;15:583\u201391.","journal-title":"Int J Gen Med"},{"issue":"11","key":"588_CR23","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.clinthera.2022.09.014","volume":"44","author":"W Shi","year":"2022","unstructured":"Shi W, et al. Efficacy and safety of the remimazolam-alfentanil combination for sedation during gastroscopy: a randomized, double-blind, single-center controlled trial. Clin Ther. 2022b;44(11):1506\u201318.","journal-title":"Clin Ther"},{"issue":"2","key":"588_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1213\/ANE.0b013e31823acb95","volume":"115","author":"JR Sneyd","year":"2012","unstructured":"Sneyd JR. Remimazolam: new beginnings or just a me-too? Anesth Analg. 2012;115(2):217\u20139.","journal-title":"Anesth Analg"},{"issue":"1","key":"588_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bja.2022.02.031","volume":"129","author":"JR Sneyd","year":"2022","unstructured":"Sneyd JR. Avoiding kidney damage in ICU sedation with sevoflurane: use isoflurane instead. Br J Anaesth. 2022;129(1):7\u201310.","journal-title":"Br J Anaesth"},{"issue":"4","key":"588_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/bja\/aew278","volume":"117","author":"GS Tomar","year":"2016","unstructured":"Tomar GS. Difficult airway society 2015 guidelines for management of unanticipated difficult intubation in adults: need to be revisited? Br J Anaesth. 2016;117(4):529.","journal-title":"Br J Anaesth"},{"key":"588_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2147\/TCRM.S199440","volume":"15","author":"L Wan","year":"2019","unstructured":"Wan L, et al. Dexmedetomidine reduces sevoflurane EC50 for supraglottic airway device insertion in spontaneously breathing morbidly obese patients. Ther Clin Risk Manag. 2019;15:627\u201335.","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"588_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.4103\/0366-6999.226897","volume":"131","author":"J Wang","year":"2018","unstructured":"Wang J, et al. Effectiveness and safety of a novel approach for management of patients with potential difficult mask ventilation and tracheal intubation: a multi-center randomized trial. Chin Med J. 2018;131(6):631\u20137.","journal-title":"Chin Med J"},{"issue":"12","key":"588_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5208","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, et al. Fiberoptic-guided tracheal intubation under precise anesthesia and topicalization with spontaneous respiration preservation for an uncooperative patient with severe postburn mentosternal contracture. Clin Case Rep. 2021;9(12): e05208.","journal-title":"Clin Case Rep"},{"issue":"9","key":"588_CR30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/phar.1806","volume":"36","author":"AM Wesolowski","year":"2016","unstructured":"Wesolowski AM, et al. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36(9):1021\u20137.","journal-title":"Pharmacotherapy"},{"key":"588_CR31","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.2147\/DDDT.S460949","volume":"18","author":"H Xu","year":"2024","unstructured":"Xu H, et al. Comparison of the safety and efficacy of remimazolam besylate versus dexmedetomidine for patients undergoing fiberoptic bronchoscopy: a prospective, randomized controlled trial. Drug des Devel Ther. 2024;18:2317\u201327.","journal-title":"Drug des Devel Ther"},{"issue":"1","key":"588_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/s13063-021-05691-x","volume":"22","author":"M Yang","year":"2021","unstructured":"Yang M, et al. Effect of remimazolam besylate compared with propofol on the incidence of delirium after cardiac surgery: study protocol for a randomized trial. Trials. 2021;22(1):717.","journal-title":"Trials"},{"issue":"4","key":"588_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4097\/kja.23939","volume":"77","author":"YM Yoo","year":"2024","unstructured":"Yoo YM, et al. The incidences of nausea and vomiting after general anesthesia with remimazolam versus sevoflurane: a prospective randomized controlled trial. Korean J Anesthesiol. 2024;77(4):441\u20139.","journal-title":"Korean J Anesthesiol"},{"issue":"12","key":"588_CR34","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.21037\/jtd.2019.11.70","volume":"11","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, et al. Spontaneous breathing anesthesia for cervical tracheal resection and reconstruction. J Thorac Dis. 2019;11(12):5336\u201342.","journal-title":"J Thorac Dis"}],"container-title":["Perioperative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13741-025-00588-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13741-025-00588-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13741-025-00588-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:49:32Z","timestamp":1759315772000},"score":1,"resource":{"primary":{"URL":"https:\/\/perioperativemedicinejournal.biomedcentral.com\/articles\/10.1186\/s13741-025-00588-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["588"],"URL":"https:\/\/doi.org\/10.1186\/s13741-025-00588-8","relation":{},"ISSN":["2047-0525"],"issn-type":[{"value":"2047-0525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective, randomized, controlled trial was approved by the Ethical Committee of Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University (Guangzhou, China) (No. 2020-KY-46), and was registered at the Chinese ClinicalTrials.gov (No. ChiCTR2100048242).This study was performed in accordance with relevant guidelines and regulations and was consistent with CONSORT guidelines. All participants agreed to join this trial and signed the consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}